OBIO – orchestra biomed holdings, inc. - ordinary shares (US:NASDAQ)
Stock Stats
News
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Form 4 Orchestra BioMed Holding For: Dec 19 Filed by: Taylor Andrew Lawrence
Form 4 Orchestra BioMed Holding For: Dec 18 Filed by: Hochman David P
Form 4 Orchestra BioMed Holding For: Dec 12 Filed by: Taylor Andrew Lawrence
Form 4 Orchestra BioMed Holding For: Dec 05 Filed by: Sherman Darren
Form 10-Q Orchestra BioMed Holding For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.